Abstract
• Background: The aim of the study was to compare the inward permeability of the blood-retinal barrier in healthy subjects from six European cities. • Methods: Seventy-two healthy subjects (age 20–70 years) were selected. At 30 min and 60 min after fluorescein injection, fluorescein mass in vitreous was calculated from the concentrations measured along the optical axis of the eye. Non-protein-bound fluorescein (NPBF) concentrations were measured in plasma prepared from blood samples taken 7, 15 and 55 min after injection. Blood-retinal barrier permeability (PBRB) was calculated from the vitreous fluorescein mass and the time integral of NPBF and was corrected for the autofluorescence of ocular tissue and for lenticular light transmittance. • Results: Mean PBRB values±SD (nm-−1) were 2.07±0.54 (Coimbra), 2.01±0.43 (Frankfurt), 2.24±0.50 (Ghent), 2.37±0.56 (Herlev), 1.89±0.44 (Leiden) and 1.74±0.38 (Porto). Differences between centers were not significant (P>0.35). Measurements were reproducible and independent of the time after fluorescein injection (P>0.50). A PBRB higher than 3.16 nm·s−1 or a value which had increased by 32% was considered abnormal (P<0.05). • Conclusion: PBRB values were similar in all centers. The results demonstrate that this is a highly sensitive and reliable method for measuring the permeability of the blood-retinal barrier.
Similar content being viewed by others
References
Baglivo E, Bloch-Michel E, Ducot B, Offret M, Offret H (1995) Quantification of blood-ocular barriers junction using fluorophotometry in intermediate uveitis. J Fr Ophthalmol 18:421–425
Benitez del Castillo JM, Castillo A, Ruibal JL, Reverte F, barra JM (1993) An 18 months vitreous fluorophotometric follow up study in juvenile diabetics. Acta Ophthalmol 71:651–656
Benitez del Castillo JM, Castillo A, Fernandez PC, Sanchez JG (1993) Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy. Doc Ophthalmol 84:127–133
Boot JP, Van Best JA, Tjin A, Tsoi EWSJ, Kappelhof JP, Oosterhuis JA (1987) Plasma fluorescein decay determination during fluorophotometry. Doc Ophthalmol 65:403–422
Boot JP, Van Gerven JM, Van Best JA, Vrij L, Lemkes HHPJ, Oosterhuis JA (1989) Blood retinal and blood aqueous barriers in diabetics by fluorophotometry. Doc Ophthalmol 71:19–27
Bordat B, Arnaud C, Guirguis IR, Laudeho A (1995) Fluorophotometric study of lens-autofluorescence and the blood retinal barrier in 56 diabetic patients. Eur J Ophthalmol 5:13–18
Bungay PM, Roy MS, Bonner RF (1989) Posterior vitreous fluorophotometry. I. Description of a new analysis procedure and results in normal subjects. Arch Ophthalmol 107:1321–1327
Cellini M, Baldi A (1991) Vitreous fluorophotometric recordings in HIV infection. Int Ophthalmol 15:37–40
Chahal PS, Chowienczyk PJ, Kohner EM (1985) Measurement of the bloodretinal barrier permeability. A reproducibility study in normal eyes. Invest Ophthalmol Vis Sci 26:977–982
Chahal PS, Fallon TJ, Kohner EM (1986) Measurement of the blood retinal barrier in central retinal vein occlusion. Arch Ophthalmol 104:554–557
Cunha-Vaz JG, Maurice DM (1967) The active transport of fluorescein by the retinal vessels and retina. J Physiol (Lond) 191:467–486
Cunha-Vaz JG, Abreu JF, Figo GH (1975) Early breakdown of the bloodretinal barriers in diabetes. Br J Ophthalmol 59:649–656
Cunha-Vaz JG, Mota CC, Leite EC, de Abreu JR, Ruas MA (1985) Effect of sulindac on the blood retinal barrier in early diabetic retinopathy. Arch Ophthalmol 103:1307–1311
Cunha-Vaz JG, Gray JR, Zeimer RC, Mota MG, Ishimoto BM, Leite E (1985) Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes 34:53–59
Cunha-Vaz JG, Mota CC, Leite EC (1986) Effect of sorbinil on the blood retinal barrier in early diabetic retinopathy. Diabetes 35:574–578
Cunha-Vaz JG, Leite EC, Sousa JC, de Abreu JR (1993) Blood retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes. A four-year follow up study. Graefe's Arch Clin Exp Ophthalmol 231:141–145
de Abreu JR, Silva R, Cunha-Vaz JG (1994) The blood-retinal barrier in diabetes during puberty. Arch Ophthalmol 112:1334–1338
Engler CB, Krogsaa B, Lund-Andersen H (1991) Blood retinal barrier permeability and its relation to progression of diabetic retinopathy in type I diabetics. A 8 year follow up study. Graefe's Arch Clin Exp Ophthalmol 229:442–446
Engler CB, Sander B, Larsen M, Dalgaard P, Lund-Andersen H (1994) Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo. Acta Ophthalmol 72:655–662
Gardner TW, Eller AW, Friberg TR, D'Antonio JA, Hollis TM (1995) Antihistamines reduce blood retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. Retina 15:134–146
Gray JR, Mosier MA, Ishimoto BM (1985) Optimized protocol for Fluorotron Master. Graefe's Arch Clin Exp Ophthalmol 222:225–229
Kappelhof JP, Van Best JA, Van Valenberg PLJ, Oosterhuis JA (1987) Inward permeability of the blood-retinal barrier by fluorophotometry. Invest Ophthalmol Vis Sci 28:665–671
Lund-Andersen H, Krogsaa B, la Cour M, Larsen J (1985) Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci 26:698–710
Merin S, Blair NP, Tso MOM (1987) Vitreous fluorophotometry in patients with senile macular degeneration. Invest Ophthalmol Vis Sci 28:756–759
Miyake K, Miyake I, Kuratoni R (1987) Longterm effects of topically applied epinefrine on the blood-ocular barrier in human. Arch Ophthalmol 105:1360–1363
Nuzzi G, Venturini I, Bonacini M, Saczi-Amade R (1987) Improvement of blood retinal barrier induced by benz adac lysine: preliminary clinical observations in insulin dependent diabetics. Arch Ophthalmol 105:1165–1166
Ogura Y, Tsukahara Y, Saito S, Kondo T (1985) Estimation of the permeability of the blood-retinal barrier in normal individuals. Invest Ophthalmol Vis Sci 26:969–976
Ogura Y, Cunha-Vaz JG, Zeimer RC (1987) Evaluation of vitreous body integrity in retinitis pigmentosa by vitreous fluorophotometry. Arch Ophthalmol 105:517–519
Raines MF, Bhargava SK, Rosen ES (1989) The blood-retinal barrier in chloroquine retinopathy. Invest Ophthalmol Vis Sci 30:1726–1731
Roy MS, Bungay PM, Bonner RF (1989) Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure. Arch Ophthalmol 107:1328–1333
Schalnus R, Ohrloff J, Jungmann E, Maaß K, Rinke S, Wagner A (1993) Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetics without diabetic retinopathy: simultaneous evaluation with fluorophotometry. German J Ophthalmol 2:202–206
Schauwvlieghe P, de Lacy JJ (1985) Fluorophotometry in retinitis pigmentosa. Bull Soc Belge Ophthalmol 215:87–94
Szymanski A, Gierek-Lapinska A, Koziak M, Gierek-Kalicka S (1992) Axial and para-axial fluorophotometry in glaucoma simplex. Int Ophthalmol 16:283–285
Van Gerven JM, Boot JP, Lemkes HHPJ, Van Best JA (1992) Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy. Doc Ophthalmol 80:183–188
Van Gerven JM, Boot JP, Lemkes HHPJ, Van Best JA (1994) Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial. Doc Ophthalmol 87:355–365
VanWirdum E, Van Best JA, Bruining GJ, De Beaufort C, Oosterhuis JA (1989) Blood-retinal and blood aqueous barrier permeability, lens autofluorescence and transmission in insulin-dependent diabetic youngsters. Graefe's Arch Clin Exp Ophthalmol 227:26–29
White NH, Waltman SR, Krupin T, Santiago JV (1982) Reversal of abnormalities in ocular fluorophotometry in insulin dependent diabetes after five months of improved metabolic control. Diabetes 31:80–85
Yoshida A, Ishiko S, Kojiwa M, Ogasawana H (1993) Permeability of the blood ocular barrier in adolescent and diabetic patients. Br J Ophthalmol 77:158–161
Zar JH (1984) In Kurtz B (ed) Biostatistical analysis, 2nd edn. Prentice Hall, Englewood Cliffs, NJ, pp 138–143, 176–179
Zeimer RC, Noth JM (1984) A new method of measuring in vivo the lens transmittance and study of lens scatter, fluorescence and transmittance. Ophthalmic Res 16:26–255
Zeimer RC, Blair NP, Cunha-Vaz JG (1983) Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer. Arch Ophthalmol 101:1753–1756
Zeimer RC, Blair NP, Cunha-Vaz JG (1983) Pharmacokinetic interpretation of vitreous fluorophotometry. Invest Ophthalmol Vis Sci 24:1374–1381
Zeimer RC, Blair NP, Cunha-Vaz JG (1984) Vitreous fluorophotometry for clinical research II. Method of dataacquisition and processing. Arch Ophthalmol 101:1757–1761
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Van Schaik, H.J., Heintz, B., Larsen, M. et al. Permeability of the blood-retinal barrier in healthy humans. Graefe's Arch Clin Exp Ophthalmol 235, 639–646 (1997). https://doi.org/10.1007/BF00946940
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00946940